476 related articles for article (PubMed ID: 26352749)
41. Detection of intracranial metastases: a multicenter, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dosage.
Colosimo C; Ruscalleda J; Korves M; La Ferla R; Wool C; Pianezzola P; Kirchin MA
Invest Radiol; 2001 Feb; 36(2):72-81. PubMed ID: 11224754
[TBL] [Abstract][Full Text] [Related]
42. Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.
Conte G; Preda L; Cocorocchio E; Raimondi S; Giannitto C; Minotti M; De Piano F; Petralia G; Ferrucci PF; Bellomi M
Eur Radiol; 2017 Oct; 27(10):4372-4378. PubMed ID: 28357495
[TBL] [Abstract][Full Text] [Related]
43. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
Rudolph A; von Knobelsdorff-Brenkenhoff F; Wassmuth R; Prothmann M; Utz W; Schulz-Menger J
J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of the effect of multiple administrations of gadopentetate dimeglumine or gadoterate meglumine on brain T1-weighted hyperintensity in pediatric patients.
Towbin AJ; Zhang B; Dillman JR
Pediatr Radiol; 2021 Dec; 51(13):2568-2580. PubMed ID: 34286351
[TBL] [Abstract][Full Text] [Related]
45. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
Pediconi F; Catalano C; Padula S; Roselli A; Dominelli V; Cagioli S; Kirchin MA; Pirovano G; Passariello R
AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
[TBL] [Abstract][Full Text] [Related]
46. T1 signal intensity in the dentate nucleus after the administration of the macrocyclic gadolinium-based contrast agent gadoterate meglumine: An observational study.
Ramalho J; Semelka RC; Cruz J; Morais T; Ramalho M
Radiologia (Engl Ed); 2022; 64(5):397-406. PubMed ID: 36243439
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
[TBL] [Abstract][Full Text] [Related]
48. Multicenter, intra-individual comparison of single dose gadobenate dimeglumine and double dose gadopentetate dimeglumine for MR angiography of the peripheral arteries (the Peripheral VALUE Study).
Wang J; Yan F; Liu J; Lu J; Li D; Luan J; Wang X; Li Y; Iezzi R; De Cobelli F
J Magn Reson Imaging; 2013 Oct; 38(4):926-37. PubMed ID: 23371919
[TBL] [Abstract][Full Text] [Related]
49. Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
Robert P; Vives V; Grindel AL; Kremer S; Bierry G; Louin G; Ballet S; Corot C
Radiology; 2020 Jan; 294(1):117-126. PubMed ID: 31660804
[TBL] [Abstract][Full Text] [Related]
50. Signal Enhancement of the Dentate Nucleus at Unenhanced MR Imaging after Very High Cumulative Doses of the Macrocyclic Gadolinium-based Contrast Agent Gadobutrol: An Observational Study.
Bjørnerud A; Vatnehol SAS; Larsson C; Due-Tønnessen P; Hol PK; Groote IR
Radiology; 2017 Nov; 285(2):434-444. PubMed ID: 28885891
[TBL] [Abstract][Full Text] [Related]
51. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
[TBL] [Abstract][Full Text] [Related]
52. MRI of colorectal cancer liver metastases: comparison of orally administered manganese with intravenously administered gadobenate dimeglumine.
Brismar TB; Kartalis N; Kylander C; Albiin N
Eur Radiol; 2012 Mar; 22(3):633-41. PubMed ID: 21953376
[TBL] [Abstract][Full Text] [Related]
53. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.
Johansson L; Kirchin MA; Ahlström H
Acta Radiol; 2012 Dec; 53(10):1112-7. PubMed ID: 23081961
[TBL] [Abstract][Full Text] [Related]
54. Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
Jaulent P; Hannoun S; Kocevar G; Rollot F; Durand-Dubief F; Vukusic S; Brisset JC; Sappey-Marinier D; Cotton F
Eur J Radiol; 2018 Aug; 105():204-208. PubMed ID: 30017281
[TBL] [Abstract][Full Text] [Related]
55. Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid.
Ichikawa S; Motosugi U; Omiya Y; Onishi H
Invest Radiol; 2017 Jul; 52(7):389-395. PubMed ID: 28195932
[TBL] [Abstract][Full Text] [Related]
56. Dentate nucleus signal intensity changes on T1-weighted MRI after repeated administrations of linear and macrocyclic gadolinium-based contrast agents: a pediatric intraindividual case-control study.
Ozturk K; Nascene D
Acta Radiol; 2022 Jul; 63(7):914-922. PubMed ID: 34018821
[TBL] [Abstract][Full Text] [Related]
57. Investigation of the longitudinal relaxation rate of blood after gadobenate dimeglumine administration: sequence optimization, dynamic acquisition, and clinical impact for contrast-enhanced MR angiography of the carotid arteries.
Neira C; Anzidei M; Napoli A; Kirchin MA; Cavallo Marincola B; Zaccagna F; Catalano C; Passariello R; Tedoldi F
Invest Radiol; 2011 Dec; 46(12):774-82. PubMed ID: 21730871
[TBL] [Abstract][Full Text] [Related]
58. Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients.
Furlan A; Close ON; Borhani AA; Wu YH; Heller MT
Clin Radiol; 2017 Jan; 72(1):93.e1-93.e6. PubMed ID: 27633725
[TBL] [Abstract][Full Text] [Related]
59. Age, But Not Repeated Exposure to Gadoterate Meglumine, Is Associated With T1- and T2-Weighted Signal Intensity Changes in the Deep Brain Nuclei of Pediatric Patients.
Pozeg P; Forget J; Meuli RA; Maeder P
Invest Radiol; 2019 Sep; 54(9):537-548. PubMed ID: 30973458
[TBL] [Abstract][Full Text] [Related]
60. Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain.
Runge VM; Parker JR; Donovan M
Invest Radiol; 2002 May; 37(5):269-80. PubMed ID: 11979153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
